v1
Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer.
Identifier:nobleid.org/w1/20260515/EB83CD60
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/EB83CD60)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims